Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Shenzhen Neptunus Bioengineering Co., Ltd.
  6. Summary
    000078   CNE000000X95

SHENZHEN NEPTUNUS BIOENGINEERING CO., LTD.

(000078)
  Report
 SummaryChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   End-of-day quote. End-of-day quote Shenzhen Stock Exchange
11/23/2021 11/24/2021 11/25/2021 11/26/2021 11/29/2021 Date
3.14 3.18 3.18 3.14 3.22 Last
8792410 14753290 22391560 10730480 37620570 Volume
+0.32% +1.27% 0.00% -1.26% +2.55% Change
Estimated financial data (e)
Sales 2019 41 493 M 6 512 M 6 512 M
Net income 2019 206 M 32,4 M 32,4 M
Net Debt 2019 6 892 M 1 082 M 1 082 M
P/E ratio 2019 47,8x
Yield 2019 -
Sales 2020 40 022 M 6 282 M 6 282 M
Net income 2020 -289 M -45,3 M -45,3 M
Net Debt 2020 8 702 M 1 366 M 1 366 M
P/E ratio 2020 -36,5x
Yield 2020 -
Capitalization 8 858 M 1 387 M 1 390 M
EV / Sales 2019 0,41x
EV / Sales 2020 0,49x
Nbr of Employees 10 484
Free-Float 52,3%
More Financials
Company
Shenzhen Neptunus Bioengineering Co.,Ltd is a China-based company principally engaged in pharmaceutical and food manufacturing and pharmaceutical commercial distribution businesses. The Company’s main products include anti-tumor products, cardiovascular drugs, marine drugs, respiratory drugs, anti-infective products and other pharmaceuticals, as well as healthcare products, health food and medical instrument. The... 
Sector
Pharmaceuticals
Calendar
04/25Earnings Release
More about the company
All news about SHENZHEN NEPTUNUS BIOENGINEERING CO., LTD.
10/27Shenzhen Neptunus Bioengineering Co., Ltd. Reports Earnings Results for the Nine Months..
CI
08/16Shenzhen Neptunus Bioengineering Co., Ltd. Reports Earnings Results for the Half Year E..
CI
04/26Shenzhen Neptunus Bioengineering Co., Ltd. Reports Earnings Results for the Full Year E..
CI
04/26Shenzhen Neptunus Bioengineering Co., Ltd. Reports Earnings Results for the First Quart..
CI
2020Jilin Neptunus Yinhe Pharmaceutical Investment Co., Ltd. announced that it expects to r..
CI
2020Shenzhen Neptunus Bioengineering Co., Ltd. Reports Earnings Results for the Nine Months..
CI
2020Shenzhen Neptunus Bioengineering Co., Ltd. cancelled the transaction announced on April..
CI
2020Shenzhen Neptunus Bioengineering Co., Ltd. announced that it expects to receive CNY 2.4..
CI
2020Shenzhen Neptunus Bioengineering Co., Ltd. Reports Earnings Results for the Half Year E..
CI
2020Shenzhen Neptunus Bioengineering Co., Ltd. Reports Earnings Results for the First Quart..
CI
2019Shenzhen Neptunus Bioengineering Co., Ltd. Reports Earnings Results for the Nine Months..
CI
2019Shenzhen Neptunus Bioengineering Co., Ltd. Announces Election of Directors
CI
2019Shenzhen Neptunus Bioengineering Co., Ltd. Reports Earnings Results for the Half Year E..
CI
2019Shenzhen Neptunus Bioengineering Co., Ltd. Implements Dividend for A Shares for the Yea..
CI
2019SHENZHEN NEPTUNUS BIOENGINEERING CO. : 000078) added to FTSE All-World Index
CI
More news
News in other languages on SHENZHEN NEPTUNUS BIOENGINEERING CO., LTD.

- No features available -

More news
Chart SHENZHEN NEPTUNUS BIOENGINEERING CO., LTD.
Duration : Period :
Shenzhen Neptunus Bioengineering Co., Ltd. Technical Analysis Chart | 000078 | CNE000000X95 | MarketScreener
Technical analysis trends SHENZHEN NEPTUNUS BIOENGINEERING CO., LTD.
Short TermMid-TermLong Term
TrendsBullishBearishNeutral
Income Statement Evolution
Managers and Directors
Feng Zhang Vice Chairman & President
Da Kai Shen CFO, Board Secretary & Director
Si Min Zhang Chairman
He Huang Chairman-Supervisory Board
Lai Ping Liu Independent Director
Sector and Competitors
1st jan.Capi. (M$)
SHENZHEN NEPTUNUS BIOENGINEERING CO., LTD.-19.70%1 351
JOHNSON & JOHNSON1.16%419 109
ROCHE HOLDING AG16.05%336 162
PFIZER, INC.46.70%303 095
NOVO NORDISK A/S67.00%247 254
ELI LILLY AND COMPANY54.21%236 049